Analysis of the Immunochemistry Market in Malaysia
Analysis of the Immunochemistry Market in Malaysia
Major Trends in the Domestic Market
RELEASE DATE
20-Aug-2015
20-Aug-2015
REGION
Asia Pacific
Asia Pacific
Research Code: 9AB9-00-38-00-00
SKU: HC02467-AP-MR_16588
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC02467-AP-MR_16588
Description
The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. The demand for immunochemistry tests in tertiary care hospitals is high. Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry analyzers. Public hospitals procure equipment using tenders, while reagents are purchased in batches 2–3 times a year. The demand for immunochemistry tests will grow, as communicable disease testing has increased and preventive tests are common.
Table of Contents
Executive Summary
Executive Summary (continued)
Scope and Segmentation
Overview of Healthcare Expenditure in Malaysia
Overview of Healthcare Expenditure in Malaysia
Overview of Healthcare Expenditure in Malaysia
Growing Demand for and Affordability of Quality Healthcare Services
Growth in Malaysian Hospitals
Parallel Public and Private Healthcare Sectors in Malaysia
Division into 4 major types that facilitate the healthcare ecosystem
Access to Public Secondary and Tertiary Service Care
Principal Cause of Death in Public Hospitals
Principal Cause of Death in Private Hospitals
Malaysian Hospitals—Market Overview
Category High Public Hospitals (>650 Beds per Hospital)—Key States
Category Medium Public Hospitals (150–650 Beds)—Key States
Category Low Public Hospitals (< 150 Beds)—Key States
Category Low Public Hospitals (< 150 Beds)—Key States (continued)
Malaysian IVD Market—Market Segmentation
Malaysian Immunochemistry Market —Customer Segmentation and Customer Expenditure Pattern
Immunochemistry Market—Revenue Forecast
Clinical Chemistry Market—Revenue Forecast
Immunoassay Market—Revenue Forecast
Immunoassay Market—Revenue Forecast by Segment
Top 3 Immunochemistry Tests in Demand in Malaysian Hospitals
Usage Pattern of Immunochemistry Equipment
Future Demand for Immunochemistry Tests After GST Implementation
Demand for Automated Immunochemistry Equipment Versus Conventional—End User’s Perspective
Procurement Process of Immunochemistry Equipment in Public Hospitals
Procurement Process of Immunochemistry Reagents in Malaysian Public Hospitals
Procurement Process of Immunochemistry Equipment in Private Hospitals and Diagnostic Laboratories
Overview of Key Competitors in the Immunochemistry Market in Malaysia
Demand for Immunochemistry Equipment in Malaysia—A Distributor’s Perspective
Key Global Companies—Roche
Key Global Companies—Siemens (Healthcare)
Key Global Companies—Abbott
Key Global Companies—Becton Dickinson
Key Local Companies—BP Healthcare
Top 3 Competitors—Immunochemistry Equipment Manufacturers
Segment Analysis of Competitors in the Immunochemistry Market
Key Distributors in the Malaysian Immunochemistry Market
Opportunity for Automated Equipment Manufacturers
New Public Hospitals in Malaysia
New Private Hospitals in Malaysia
Key Market Drivers
Key Market Restraints
Future Trends in the Malaysian Immunochemistry Market
Category Low Public Hospitals (< 150 beds)—Other States
Category Low Public Hospitals (< 150 beds)—Other States
Category Medium Public Hospitals (150 beds-650 beds)—Other States
Category High Public Hospitals (>650 beds)—Other States
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Related Research
Popular Topics
The Malaysian immunochemistry market is dominated by Roche, Siemens, and Beckman Coulter. Other participants are Becton Dickenson, Abbott, Sysmex, and some Chinese companies. The demand for immunochemistry tests in tertiary care hospitals is high. Automated equipment is preferred but some tier I and II hospitals operate on semi-automated chemistry analyzers. Public hospitals procure equipment using tenders, while reagents are purchased in batches 2–3 times a year. The demand for immunochemistry tests will grow, as communicable disease testing has increased and preventive tests are common.
No Index | No |
---|---|
Podcast | No |
Author | Siddharth Dutta |
Industries | Healthcare |
WIP Number | 9AB9-00-38-00-00 |
Is Prebook | No |